Pediatric ALL

0

Pipeline Programs↗

3

Active Trials↗

0

Companies Involved↗

Pediatric ALL is an early-stage landscape with 0 programs across 0 companies.

Intelligence

Pipeline Metrics

Competitive Density

14/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

67/100

Attrition Rate

17/100

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

6

clinical trials

Recruiting2 · 33%

Completed2 · 33%

Not yet recruiting1 · 17%

Terminated1 · 17%

Clinical Trials

Trial Activity

6 trials

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of Haplo-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL

Recruiting·TThe First Affiliated Hospital of Zhengzhou University·Phase 2·NCT06559345·276 enrolled

A Prospective, Open-label, Randomized Controlled, Multicenter Clinical Study of MSD-HSCT Using a TBI or TMLI Conditioning Regimen for Pediatric ALL

Recruiting·TThe First Affiliated Hospital of Zhengzhou University·Phase 2·NCT06564493·170 enrolled

Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL

Not yet recruiting·—·Phase 2/3·NCT07297914·1,000 enrolled

A Pilot Study of Allopurinol As A Modifier of 6-MP Metabolism in Pediatric ALL

Completed·SSidney Kimmel Comprehensive Cancer Center at Johns Hopkins·Phase 1·NCT02046694·34 enrolled

Gut Decontamination In Pediatric Allogeneic Hematopoietic

Completed·—·Phase 2·NCT02641236·24 enrolled

ABT-751 With Chemotherapy for Relapsed Pediatric ALL

Terminated·TTherapeutic Advances in Childhood Leukemia Consortium·Phase 1/2·NCT00439296·9 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)